Advanced glycation end products: sparking the development of diabetic vascular injury.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-08-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.621854PMID 16894049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with Type 2 diabetes mellitus

  2005cited by this paper
• The Role of Reactive Oxygen Species in Insulin Signaling in the Vasculature

  2005cited by this paper
• Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.

  2005cited by this paper
• Pathological Roles of Advanced Glycation End Product Receptors SR‐A and CD36

  2005cited by this paper
• CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells.

  2005cited by this paper
• Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat

  2004cited by this paper
• RAGE Axis: Animal Models and Novel Insights Into the Vascular Complications of Diabetes

  2004cited by this paper
• Advanced glycoxidation end products in commonly consumed foods.

  2004cited by this paper
• Protein Glycation: A Firm Link to Endothelial Cell Dysfunction

  2004cited by this paper
• Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.

  2004cited by this paper
• Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

  2004cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

  2004cited by this paper
• Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

  2004cited by this paper
• High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients

  2004cited by this paper
• Crosslink breakers: a new approach to cardiovascular therapy

  2004cited by this paper
• A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes

  2003cited by this paper
• Scavenger receptors for oxidized and glycated proteins

  2003cited by this paper
• Modification of Proteins In Vitro by Physiological Levels of Glucose

  2003cited by this paper
• Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

  2003cited by this paper
• Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs.

  2003cited by this paper
• Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

  2003cited by this paper
• Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products

  2003cited by this paper
• The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.

  2003cited by this paper
• Getting Better Without AGE New Insights Into the Diabetic Heart

  2003cited by this paper
• Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

  2003cited by this paper
• FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products*

  2003cited by this paper
• The insulin gene variable number tandem repeat class I/III polymorphism is in linkage disequilibrium with birth weight but not Type 2 diabetes in the Pima population.

  2003cited by this paper
• Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

  2002cited by this paper
• Lectin‐like oxidized low density lipoprotein receptor‐1 (LOX‐1) serves as an endothelial receptor for advanced glycation end products (AGE)

  2002cited by this paper
• RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

  2002cited by this paper
• Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

  2002cited by this paper
• Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

  2002cited by this paper
• Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

  2002cited by this paper
• ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

  2002cited by this paper
• The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

  2002cited by this paper
• Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

  2002cited by this paper
• Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats

  2002cited by this paper
• Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses

  2002cited by this paper
• RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

  2002cited by this paper
• Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

  2002cited by this paper
• Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products*

  2001cited by this paper
• Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.

  2001cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE.

  2001cited by this paper
• Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose

  2001cited by this paper
• Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.

  2001cited by this paper
• Advanced glycation end-products: a review

  2001cited by this paper
• Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker

  2001cited by this paper
• Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

  2001cited by this paper
• The AGE‐receptor in the pathogenesis of diabetic complications

  2001cited by this paper
• Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

  2001cited by this paper
• Renoprotective effects of a novel inhibitor of advanced glycation

  2001cited by this paper
• Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.

  2000cited by this paper
• Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products.

  2000cited by this paper
• Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.

  2000cited by this paper
• In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.

  2000cited by this paper
• An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

  2000cited by this paper
• RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.

  2000cited by this paper
• Nitric oxide inhibits the formation of advanced glycation end products.

  2000cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression*

  1999cited by this paper
• Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.

  1999cited by this paper
• Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.

  1999cited by this paper
• Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells.

  1999cited by this paper
• High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression.

  1999cited by this paper
• Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

  1999cited by this paper
• The effect of advanced glycation end-product formation upon cell-matrix interactions.

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways*

  1999cited by this paper
• High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression

  1999cited by this paper
• Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.

  1998cited by this paper
• Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.

  1998cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.

  1998cited by this paper
• Accumulation of Nσ-(Carboxy-methyl)lysine and Changes inGlomerular Extracellular MatrixComponents in Otsuka Long-EvansTokushima Fatty Rat:A Model of Spontaneous NIDDM

  1998cited by this paper
• Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

  1998cited by this paper
• Role of the Maillard Reaction in Aging of Tissue Proteins

  1998cited by this paper
• Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients.

  1998cited by this paper
• Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products*

  1997cited by this paper
• Induction of TNF alpha and IL-1 beta mRNA in monocytes by methylglyoxal- and advanced glycated endproduct-modified human serum albumin.

  1997cited by this paper
• Atherogenesis and Advanced Glycation: Promotion, Progression, and Prevention a

  1997cited by this paper
• Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.

  1997cited by this paper
• Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

  1996cited by this paper
• Administration of AGEs in vivo induces extracellular matrix gene expression.

  1996cited by this paper
• Roles of advanced glycation end-products in the progression of diabetic nephropathy.

  1996cited by this paper
• Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation.

  1996cited by this paper
• Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

  1996cited by this paper
• Molecular genetics of human renal cell tumours.

  1996cited by this paper
• The S100 family of EF-hand calcium-binding proteins: functions and pathology.

  1996cited by this paper
• Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.

  1996cited by this paper
• Identification of p90, a Prominent Tyrosine-phosphorylated Protein in Fibroblast Growth Factor-stimulated Cells, as 80K-H (*)

  1996cited by this paper
• Protein prenylation: molecular mechanisms and functional consequences.

  1996cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995cited by this paper
• PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.

  1995cited by this paper
• The dark side of glucose

  1995cited by this paper
• Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

  1995cited by this paper
• Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex

  1995cited by this paper

• Pirfenidone ameliorates dexamethasone-induced steatohepatitis and vascular resistance in rats.

  2026cites this paper
• Immunological mechanisms and therapeutic advances in diabetic neuropathy

  2026cites this paper
• Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer

  2026cites this paper
• Dietary advanced glycation end products (AGEs) and type 2 diabetes (T2D): a case-control study.

  2026cites this paper
• Periodontitis and Systemic Health: An Interconnected Relationship.

  2026cites this paper
• Harnessing the interplay between tendon stem/progenitor cell and microenvironment boosts tendon tissue regeneration

  2026cites this paper
• Ethyl acetate fraction of Striga hermonthica (Delile) Benth. Inhibits AGEs-mediated inflammatory markers in THP-1 monocytes.

  2026cites this paper
• A Study of the Relationship Between Serum Albumin–Corrected Fructosamine and Type 2 Diabetic Retinopathy

  2026cites this paper
• Utility of diffusion tensor imaging for assessing bone quality in type 2 diabetes: correlation with bone turnover biomarkers

  2026cites this paper
• Comparative study of pulp- and seed-derived polysaccharides from Elaeagnus conferta Roxb.: Physicochemical properties and in vitro hypoglycemic, antiglycation, and prebiotic activities

  2026cites this paper
• Study of the prognostic value of the systemic immune-inflammation index combined with the triglyceride-glucose index in coronary heart disease: a retrospective study based on the MIMIC database

  2026cites this paper
• The AGE–RAGE Pathway in Endometriosis: A Focused Mechanistic Review and Structured Evidence Map

  2026cites this paper
• Exclusive association of non-HDL/HDL ratio with albuminuria in diabetes and its nonlinear pattern in advanced CKD: Findings from NHANES 2015-2020.

  2026cites this paper
• Pentosidine accumulation induced by Akr1a deficiency Drives aggression and hyperactivity.

  2026cites this paper
• Aerobic exercise training attenuates cardiac inflammation and fibrosis in mice with type 2 diabetes and inhibits the advanced glycation end products pathway

  2026cites this paper
• Role and mechanisms of vascular smooth muscle cell phenotypic transition in diabetic macrovascular complications

  2026cites this paper
• Redox-active microneedles for disease management.

  2026cites this paper
• Residual glucose metabolism and Long-Term clinical outcomes in multivessel coronary artery disease: A cohort study

  2026cites this paper
• Optical coherence tomography and histological assessment of cutaneous vasculature and neural changes in long-term smokers: an exploratory study

  2026cites this paper
• Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS.

  2026cites this paper
• Next-generation therapeutics for diabetic kidney disease.

  2026cites this paper
• The AGE-RAGE-oxidative stress axis: A paradigm shift in understanding diabetic retinopathy.

  2026cites this paper
• Novel Plasma Proteomics and Phosphoproteomics Platform Captures Pleiotropic Cardiometabolic Spectrum Effects of Semaglutide in Patients with T2D and Atherosclerosis: A Companion Diagnostic Pilot Study from the STOP (Semaglutide Treatment On coronary atherosclerosis Progression) Randomized Trial

  2026cites this paper
• Pyridoxamine reduces inflammatory and microcirculatory abnormalities in metabolic dysfunction-associated steatohepatitis and modulates key factors in the hepatic AGE/ALE signaling pathway

  2026cites this paper
• Diabetes-induced Multiorgan Damage: Can Magnesium Delay the process?

  2026cites this paper
• Increased AGEs/sRAGE ratio and dyslipidemia risk in Down syndrome youths: a cross-sectional study

  2025cites this paper
• Microscopic Structure of Vascular Endothelial Cells with Special Reference to Coronary Artery Disease and Diabetes Mellitus

  2025cites this paper
• Comparative study of Idesia polycarpa Maxim cake meal polysaccharides: Conventional versus innovative extraction methods and their impact on structural features, emulsifying, antiglycation, and hypoglycemic properties.

  2025cites this paper
• Dietary Advanced Glycation End Products and Superovulation with Gonadotropins Alters RAGE expression in the Ovaries Differently at Each Follicular Stage of Development.

  2025cites this paper
• UTE MRI technical developments and applications in osteoporosis: a review

  2025cites this paper
• Effect of Planting Systems on the Physicochemical Properties and Bioactivities of Strawberry Polysaccharides

  2025cites this paper
• Association between estimated glucose disposal rate and prediction of cardiovascular disease risk among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study

  2025cites this paper
• Being a Target for Glycation by Methylglyoxal Contributes to Therapeutic Efficacy of Injectable Collagen Hydrogels Post-Myocardial Infarction

  2025cites this paper
• Lower hemoglobin levels may increase the risk of diabetic retinopathy in patients with type 2 diabetes mellitus

  2025cites this paper
• Association between glycation gap and impaired cardiorespiratory fitness: evidence from American adults

  2025cites this paper
• Biomarkers for diabetic peripheral neuropathy: A narrative review of advanced glycation end products

  2025cites this paper
• A comprehensive review on the Advanced Glycation End Products detection: From conventional to advanced approaches.

  2025cites this paper
• Prognostic stratification of coronary microvascular dysfunction in STEMI patients with or without diabetes mellitus.

  2025cites this paper
• Association between skin autofluorescence and all-cause mortality, cardiovascular mortality and cardiovascular disease: a systematic review and meta-analysis.

  2025cites this paper
• Redox imbalance and oxidative stress in cardiovascular diseases: mechanisms, biomarkers, and therapeutic targets

  2025cites this paper
• Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review

  2025cites this paper
• Association between non-dipper blood pressure pattern and coronary artery disease burden in hypertensive patients

  2025cites this paper
• NETosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities.

  2025cites this paper
• The interplay between diabetes and atherosclerosis: A review of pathophysiological mechanisms

  2025cites this paper
• The interrelationship between the frequency and severity of entrapment neuropathies and HbA1c in patients with diabetes in short and long term: A retrospective cohort study.

  2025cites this paper
• Azeliragon attenuates cerebral infarction aggravation in diabetic rats: Receptor for advanced glycation end-product as a novel therapeutic target.

  2025cites this paper
• Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies

  2025cites this paper
• Dietary Advanced Glycation End Products (dAGEs): Pathogenesis and nutritional strategies for health longevity-A critical view.

  2025cites this paper
• Familial risk of carpal tunnel syndrome among first-degree relatives and interaction with obesity and hyperglycemia-a population-based study in Korea.

  2025cites this paper
• Disparities in Peripheral Circulatory Complication‐Related Mortality in Type 2 Diabetes Mellitus Patients: A CDC Analysis (1999–2020)

  2025cites this paper
• Binding between Different Types of Oligopeptide-AGEs and the V Domain of RAGE: Modulation by Lotus Seedpod Oligomeric Procyanidins.

  2025cites this paper
• Aging, biofilms, and diabetic foot ulcers: disrupting chronic infections with super-oxidized solutions and addressing age-related vulnerabilities

  2025cites this paper
• Advanced wound healing with Stimuli-Responsive nanozymes: mechanisms, design and applications

  2025cites this paper
• Sex-specific differences of advanced glycation end products in diabetes

  2025cites this paper
• Association of glucose to lymphocyte ratio with all-cause and cardio-cerebrovascular mortality in diabetic population

  2025cites this paper
• Extracellular matrix in vascular homeostasis and disease

  2025cites this paper
• Clonal haematopoiesis of indeterminate potential and risk of microvascular complications among individuals with type 2 diabetes: a cohort study.

  2025cites this paper
• Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications

  2025cites this paper
• Dietary Advanced Glycation End Products (AGEs): A Modifiable Risk Factor in the Prevention of Chronic Diseases Associated with Aging?

  2025cites this paper
• MicroRNA functions in osteogenic differentiation of periodontal ligament stem cells: a scoping review

  2025cites this paper
• Does 10-Year Atherosclerotic Cardiovascular Disease Risk Predict Incident Diabetic Nephropathy and Retinopathy in Patients with Type 2 Diabetes Mellitus? Results from Two Prospective Cohort Studies in Southern China

  2025cites this paper
• Shoulder pain among type 2 diabetes mellitus patients: A cross-sectional study in Chilean population.

  2025cites this paper
• Plasma Reactive Dicarbonyls Are Not Independently Associated With Arterial Stiffness: The Maastricht Study

  2025cites this paper
• Advanced glycation end product (AGE) crosslinking of a bacterial protein: Are AGE-modifications going undetected in our studies?

  2025cites this paper
• Microvascular diseases predict mortality and cardiovascular events in type 2 diabetes: A retrospective cohort study.

  2025cites this paper
• Cryo-EM structure of HMGB1-RAGE complex and its inhibitory effect on lung cancer.

  2025cites this paper
• Diabetic neuropathy: cutting-edge research and future directions

  2025cites this paper
• Neuroprotective Effects of a Combination of Dietary Trans-Resveratrol and Hesperidin Against Methylglyoxal-Induced Neurotoxicity in a Depressive Amnesia Mouse Model

  2025cites this paper
• The associations between skin advanced glycation end-products and Framingham cardiovascular risk in different age groups

  2025cites this paper
• [Mechanism of Cnidii Fructus in the treatment of periodontitis with osteoporosis based on network pharmacology, molecular docking, and molecular dynamics simulation].

  2025cites this paper
• Diabetes mellitus aggravates myocardial inflammation and oxidative stress in aortic stenosis: a mechanistic link to HFpEF features

  2025cites this paper
• Circulating HMGB2 Is Associated With Angiographic Coronary Collateralization in Diabetic Patients With Chronic Total Occlusion and Impairs Vessel Growth via NLRP3.

  2025cites this paper
• Advancing Covalent Ligand and Drug Discovery beyond Cysteine

  2025cites this paper
• Evaluating the Association Between Obesity and Development of Trigger Finger and Carpal Tunnel Syndrome

  2025cites this paper
• Rhamnan Sulfate from the Seaweed Monostroma nitidum May Improve Cognitive Impairment Caused by Hyperglycemia

  2025cites this paper
• Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model.

  2025cites this paper
• Advanced glycation end products induce autophagy in endothelial cells through oxidative stress and regulation of the RhoA-mTOR signaling pathway.

  2025cites this paper
• Concomitant Diabetes and Atrial Fibrillation: Epicardial Fat and Macrophage‐Related Mechanisms

  2025cites this paper
• Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress

  2025cites this paper
• Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome

  2025cites this paper
• Cardiovascular complications in Diabetes: The role of NLRP3 inflammasome and targeted interventions

  2025cites this paper
• Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases

  2025cites this paper
• Integrative analysis of inhibition of advanced glycation end-products accumulation and prevention of aging muscle deterioration in animals and human models.

  2025cites this paper
• Advanced Glycation End Products: A Promising Prognostic Indicator in Breast Cancer Patients.

  2025cites this paper
• The effect of receptor for advanced glycation end products (RAGE) expression on the occurrence, development, and prognosis of gastric cancer.

  2025cites this paper
• The additive effect of cardiopulmonary fitness and triglyceride-glucose index on the risk of metabolic syndrome

  2025cites this paper
• 1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline

  2025cites this paper
• Synthesis of new 1,1-dioxido-3-oxobenzo[d]isothiazole-linked 1,2,3-triazole derivatives and evaluation of antiglycation activity: An outlook for anti-diabetic agents

  2025cites this paper
• Adipocyte Leptin Signaling Regulates Glycemia and Cardiovascular Function via Enhancing Brown Adipose Tissue Thermogenesis in Obese Male Mice

  2025cites this paper
• Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome

  2025cites this paper
• Cross‐Species Molecular Similarities Based on Omics Approaches in CKD: Toward Improved Translation From Pre‐Clinical Models to Humans

  2025cites this paper
• Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

  2025cites this paper
• Multidimensional Evaluation of Vascular Dysfunction in Diabetic Erectile Dysfunction: Synergistic Application of ICP Measurement, Laser Speckle Blood Perfusion Imaging, and Ex Vivo Microvascular Tension Measurement

  2025cites this paper
• Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus

  2025cites this paper
• Association between hemoglobin glycation index and the risk of cardiovascular disease in early-stage cardiovascular-kidney-metabolic syndrome: evidence from the China health and retirement longitudinal study

  2025cites this paper
• Association between the triglyceride glucose-Chinese visceral adiposity index and new-onset stroke risk: a national cohort study

  2025cites this paper
• Liquid‒liquid phase separation and poly(ADP‒ribosyl)ation in the context of ultraviolet radiation-induced stress in mammalian cells

  2025cites this paper
• Revolutionizing drug delivery strategies with probucol to Combat oxidative stress in retinal Degeneration: A comprehensive review.

  2025cites this paper
• Role of Galactosylceramide Metabolism in Satellite Glial Cell Dysfunction and Neuron–Glia Interactions in Painful Diabetic Peripheral Neuropathy

  2025cites this paper
• Proximal cysteine residues in proteins promote Nε-carboxyalkylation of lysine residues by α-dicarbonyl compounds

  2025cites this paper